Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

10.1038/s41525-018-0058-3

Saved in:

Bibliographic Details
Main Authors:	Lawrence, B, Blenkiron, C, Parker, K
Other Authors:	SURGERY
Format:	Article
Published:	2020
Subjects:	BRCA2 protein CD56 antigen chromogranin A cyclin dependent kinase inhibitor 1B DNA glycosylase MutY DNA mismatch repair protein MSH2 fibroblast growth factor receptor 3 Janus kinase 2 messenger RNA phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase RNA synaptophysin von Hippel Lindau protein aneuploidy Article cancer prognosis cancer susceptibility carcinogenesis cell differentiation chromosome 11 clinical outcome disease severity flcn gene gene gene expression gene mutation genetic variability heterozygosity loss human human tissue major clinical study men1 gene microarray analysis New Zealand pancreas islet cell tumor priority journal progression free survival RNA methylation single nucleotide polymorphism whole genome sequencing
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/177814
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-177814
record_format	dspace
spelling	sg-nus-scholar.10635-1778142024-04-25T02:38:40Z Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer Lawrence, B Blenkiron, C Parker, K SURGERY BRCA2 protein CD56 antigen chromogranin A cyclin dependent kinase inhibitor 1B DNA glycosylase MutY DNA mismatch repair protein MSH2 fibroblast growth factor receptor 3 Janus kinase 2 messenger RNA phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase RNA synaptophysin von Hippel Lindau protein aneuploidy Article cancer prognosis cancer susceptibility carcinogenesis cell differentiation chromosome 11 clinical outcome disease severity flcn gene gene gene expression gene mutation genetic variability heterozygosity loss human human tissue major clinical study men1 gene microarray analysis New Zealand pancreas islet cell tumor priority journal progression free survival RNA methylation single nucleotide polymorphism whole genome sequencing 10.1038/s41525-018-0058-3 npj Genomic Medicine 3 1 18 2020-10-20T03:26:12Z 2020-10-20T03:26:12Z 2018 Article Lawrence, B, Blenkiron, C, Parker, K (2018). Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer. npj Genomic Medicine 3 (1) : 18. ScholarBank@NUS Repository. https://doi.org/10.1038/s41525-018-0058-3 20567944 https://scholarbank.nus.edu.sg/handle/10635/177814 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	BRCA2 protein CD56 antigen chromogranin A cyclin dependent kinase inhibitor 1B DNA glycosylase MutY DNA mismatch repair protein MSH2 fibroblast growth factor receptor 3 Janus kinase 2 messenger RNA phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase RNA synaptophysin von Hippel Lindau protein aneuploidy Article cancer prognosis cancer susceptibility carcinogenesis cell differentiation chromosome 11 clinical outcome disease severity flcn gene gene gene expression gene mutation genetic variability heterozygosity loss human human tissue major clinical study men1 gene microarray analysis New Zealand pancreas islet cell tumor priority journal progression free survival RNA methylation single nucleotide polymorphism whole genome sequencing
spellingShingle	BRCA2 protein CD56 antigen chromogranin A cyclin dependent kinase inhibitor 1B DNA glycosylase MutY DNA mismatch repair protein MSH2 fibroblast growth factor receptor 3 Janus kinase 2 messenger RNA phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase RNA synaptophysin von Hippel Lindau protein aneuploidy Article cancer prognosis cancer susceptibility carcinogenesis cell differentiation chromosome 11 clinical outcome disease severity flcn gene gene gene expression gene mutation genetic variability heterozygosity loss human human tissue major clinical study men1 gene microarray analysis New Zealand pancreas islet cell tumor priority journal progression free survival RNA methylation single nucleotide polymorphism whole genome sequencing Lawrence, B Blenkiron, C Parker, K Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
description	10.1038/s41525-018-0058-3
author2	SURGERY
author_facet	SURGERY Lawrence, B Blenkiron, C Parker, K
format	Article
author	Lawrence, B Blenkiron, C Parker, K
author_sort	Lawrence, B
title	Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
title_short	Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
title_full	Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
title_fullStr	Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
title_full_unstemmed	Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
title_sort	recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/177814
_version_	1800914461126557696

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

Similar Items